BRIEF-AstraZeneca completes Bristol-Myers diabetes acquisition

Feb 3 (Reuters) - AstraZeneca PLC : * AstraZeneca completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb's interests in the companies' diabetes alliance * For more news, please click here
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.